Skip to content

Restructuring Charges at other companies

Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$0-100%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
-$63K-104%

Segments

By segment

See full
Reportable Segment$0-100%

Other financials

Income statement

See full
Revenue$179.1M+10,055%
Operating income$168.9M+757%
Net income$169.7M+792%
EPS (diluted)$0.87+769%

Balance sheet

See full
Cash & equivalents$23.7M-36.1%
Total debt$631.0K-46.9%
Total equity$260.2M+229%
Total assets$277.2M+137%

Cash flow

See full
Operating cash flow-$8.1M+39.4%
CapEx--100%
Free cash flow-$4.7M+55.0%

Valuation

See full
Market cap$881.02M+34.1%
Enterprise value$857.94M+38.1%
P/E5.5×
P/S4.6×-98.0×

Profitability

See full
Operating margin81.7%+42.1pp
Net margin84%+43.4pp
FCF margin-281.5%-119pp

Returns & leverage

See full
Return on equity94.7%+65.1pp
Debt / equity0.0×
Current ratio54.3×+48.3×

Where this comes from

Reported directly by Arbutus Biopharma Corporation in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCharges.

The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arbutus Biopharma Corporation's restructuring charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arbutus Biopharma Corporation's restructuring charges?
Arbutus Biopharma Corporation (ABUS) reported restructuring charges of $0 in Q1 2026.
How has Arbutus Biopharma Corporation's restructuring charges changed year-over-year?
Arbutus Biopharma Corporation's restructuring charges decreased by 100.0% year-over-year, from $12.37M to $0.
What does restructuring charges mean?
One-time costs from reorganizing operations, including employee severance, facility closure costs, contract termination fees, and asset relocation expenses.